Anti-CD25 mAb, Anti-IL2 mAb, and IL2 Block Tolerance Induction Through Anti-CD154 mAb and Rapamycin in Xenogeneic Islet Transplantation

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3452-3454

  Pan, H ^a   Lu, H M ^a   Hu, W M ^a   Tian, B L ^a   Liu, X B ^a   Zhang, Z D ^a   Mai, G ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 MONOCLONAL ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; RAPAMYCIN; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; DIABETES MELLITUS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; STREPTOZOCIN DIABETES; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CD40 LIGAND; CRICETINAE; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; SIROLIMUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 37049022155     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.091     Document Type: Article

References (8)

1. Li Y., Li X.C., Zeng X.X., et al. Blocking both signal 1 and signal 2 of T cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5 (1999) 1303
2. Wells A.D., Li X.C., Li Y., et al. Requirement for T cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5 (1999) 1039
3. Wekerle T., Kurtz J., Bigenzahn S., et al. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14 (2002) 592
4. Mai G., Bucher P., Morel P., et al. Anti-CD154 mAb treatment but not recipient CD154 deficiency leads to long-term survival of xenogeneic islet grafts. Am J Transplant May 5 (2005) 1021
5. Bucher P., Gang M., Morel P., et al. Transplantation of discordant xenogeneic islets using repeated therapy with anti-CD154. Transplantation 79 (2005) 1545
6. Auchincloss H. In search of the elusive holy grail: the mechanisms and prospects of achieving clinical transplantation tolerance. Am J Transplant 1 (2001) 6
7. Tran H.M., Nickerson P.W., Restifo A.C., et al. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J Immunol 159 (1997) 2232
8. Ikemoto T., Tashiro S., Yasutomo K., et al. Donor-specific tolerance induced by simultaneous allogeneic islet transplantation with CD4+CD25+ T-cells into hepatic parenchyma in mice. J Med Invest 51 (2004) 178